Haematology and haemato-oncology in Germany
The haematology centres that work with msp group germany offer the full range of the latest advances in modern medicine to patients with benign and malignant diseases of the blood and lymphatic systems (in particular anaemias, enlarged lymph nodes, acute and chronic leukaemias, myelodysplastic syndrome, myeloproliferative disorders, Hodgkin and non-Hodgkin lymphoma, multiple myeloma and aplastic anaemia).
Cancer treatment in Germany is provided both in dedicated haematology centres and in comprehensive cancer, haemostaseology and stem cell transplantation centres. The care of every cancer patient is an interdisciplinary effort — bringing together oncologists, surgeons, radiologists, specialists in nuclear and radiation medicine and psycho-oncologists. All the haematology centres are certified by the European Society for Medical Oncology (ESMO).
The services offered by haematology clinics cover every advanced form of cancer therapy (conventional chemotherapy, innovative treatment with monoclonal antibodies, and molecular targeted therapy using the latest medicinal products). The outstanding quality of care at the stem cell and bone marrow transplantation centres is confirmed by certificates from specialised scientific oncology societies and organisations,
Alongside their inpatient wards, these centres also include outpatient departments and oncology day clinics.
The haemato-oncology units work closely with certified interdisciplinary cancer centres at university hospitals. Every case is reviewed in detail by oncology expert boards, which draw up cancer treatment recommendations in line with current standards.
Laboratory research investigates the genetic causes of haematological diseases and develops new treatments for cancers and blood disorders. The molecular cytogenetic diagnostic laboratories are certified and serve as centres for national and international genetic research.
German haematology clinics offer a wide range of clinically validated molecular genetic diagnostic methods. They give patients with blood disorders the opportunity to take part in clinical trials of pioneering treatments. The clinics' research staff are recognised national and international authorities in their field.
